Pyridostigmine and Human Growth Hormone (HGH)
Pyridostigmine , classified as a type of parasympathomimetic (acetylcholinesterase inhibitor,), is used to treat muscle weakness in people with myasthenia gravis or forms of congenital myasthenic syndrome and to combat the effects of curariform drug toxicity. Pyridostigmine bromide has been FDA approved for military use during combat situations. It is used to treat underactive bladder. It is sometimes also used to treat orthostatic hypotension. It may also be of benefit in chronic axonal polyneuropathy. It is also being prescribed 'off-label' for postural orthostatic tachycardia syndrome. Human Growth Hormone (HGH) or somatotropin, is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. GH also stimulates production of Insulin-like growth factor 1 (IGF-1) and increases the concentration of glucose and free fatty acids. Pyridostigmine (PD) and Human Growth Hormone (HGH) Previo